Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

25.73 +0.03 (+0.12%)
Official Closing Price Updated: 7:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
35 36 Next >
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
From Pfizer Inc.
Via Business Wire
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
In 2016, Americans spent roughly $380 billion on lower back and neck pain. In the same year, medical costs for adult obesity in the United States were $260.6 billion. That’s why BioRestorative... 
Via TheNewswire.com
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
From Pfizer Inc.
Via Business Wire
Are You at Increased Risk of Getting Pneumococcal Pneumonia?
Via StatePoint Media
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),... 
Via SBWire
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
From Pfizer Inc.
Via Business Wire
Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
From Pfizer Inc.
Via Business Wire
Non-Steroidal Anti-Inflammatory Drugs Market Size, Share, Industry Analysis, Segmentation by Disease Indication, Distribution Channel and Forecasts 2022-2028
Global Non-steroidal Anti-inflammatory Drugs Market SWOT Analysis Including Key Players Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd.,... 
Via SBWire
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
From Pfizer Inc.
Via Business Wire
Dr. Amy Hanson selected as Top Pharmacist of the Year for 2022 by IAOTP
New York, NY, United States - 08-22-2022 - 
Via PR Distribution
Exposures COVID-19
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Is Sanofi A Buy, Despite Recent Stumbles?
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Emery Pharma Announces New Biologics Analytical Division
Supporting end-to-end research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars, and more 
Via Newswire.com
Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants
From Pfizer Inc.
Via Business Wire
NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
From Pfizer Inc.
Via Business Wire
The Power of Science to Stop a Killer
Via Investor Brand Network
The Power of Science to Stop a Killer
NetworkNewsWire Editorial Coverage New York, NY – August 8, 2022 – Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114... 
Via FinancialNewsMedia
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
From Pfizer Inc.
Via Business Wire
3 Pharma Stocks' Post-Earnings Price Moves
The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
3 Health Care Stocks in Great Financial Health
Health care’s potential to do better in both up and down markets makes it a valuable part of a long-term investment strategy. 
Via MarketBeat
Raphe Pharmaceutique Vendor Generic & OTC Self Care Contract Manufacturing Pharmaceutical Company Located in Dallas Texas
Via AB Newswire
Amphetamine Drug Market 2022: Industry Analysis, Size, Global Trends, Share, Growth, Opportunity and Forecast to 2028
Amphetamine Drug Market SWOT Analysis Including Key Players Pfizer, Novartis, Eli Lilly, GSK, Hisamitsu Pharmaceutical, Purdue Pharma 
Via SBWire
PFIZER REPORTS SECOND-QUARTER 2022 RESULTS
From Pfizer Inc.
Via Business Wire
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
Via ACN Newswire
Topics Intellectual Property
Exposures Intellectual Property
Vaccines Market Expected to Witness a Sustainable Growth by 2032 - Future Market Insights, Inc.
FMI predicts vaccines market to reach a valuation of US $120B by 2032. Key Players - Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson &... 
Via Newswire.com
Exposures COVID-19
Amy Mulroy, MD, a Psychiatrist in Private Practice
Get to know Psychiatrist Dr. Amy Mulroy, who serves patients in San Antonio, Texas. 
Via IssueWire
Is it Time to Cash Out Novavax Stock?
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. 
Via MarketBeat
Exposures COVID-19 Product Safety
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.